# Use of 1-MNA to Improve Exercise Tolerance and Fatigue in Patients After COVID-19

> **NCT04961476** · — · COMPLETED · sponsor: **Michal Chudzik** · enrollment: 50 (actual)

## Conditions studied

- Covid19
- Fatigue Syndrome, Chronic

## Interventions

- **DIETARY_SUPPLEMENT:** 1-MNA

## Key facts

- **NCT ID:** NCT04961476
- **Lead sponsor:** Michal Chudzik
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2021-01-08
- **Primary completion:** 2021-03-05
- **Final completion:** 2021-03-05
- **Target enrollment:** 50 (ACTUAL)
- **Last updated:** 2021-07-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04961476

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04961476, "Use of 1-MNA to Improve Exercise Tolerance and Fatigue in Patients After COVID-19". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04961476. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*